RABEP1 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-47285APC
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot (Negative)
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen for this product maps to a region between residue 300 and 350 of human Rabaptin, RAB GTPase Binding Effector Protein 1 using the numbering given in entry NP_004694.2 (GeneID 9135).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for RABEP1 Antibody [Allophycocyanin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: RABEP1
Alternate Names
neurocrescin, rab GTPase-binding effector protein 1, RAB5EPRABPT5A, rabaptin, RAB GTPase binding effector protein 1, Rabaptin-4, rabaptin-5, Rabaptin-5alpha, RABPT5rabaptin-5alpha, Renal carcinoma antigen NY-REN-17
Gene Symbol
RABEP1
Additional RABEP1 Products
Product Documents for RABEP1 Antibody [Allophycocyanin]
Product Specific Notices for RABEP1 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...